FDA Inspection 1113166 — Labcorp Early Development Laboratories, Inc.
The FDA completed an inspection of Labcorp Early Development Laboratories, Inc. on November 21, 2019 in Greenfield, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Greenfield, IN (United States)